arrow
R

Rafael Lozano

university of washington
H指数:107
被引数:21.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of overweight and obesity and the burden of high body-mass index in Latin America: a systematic analysis for the Global Burden of Disease Study 2023

拉丁美洲超重和肥胖的流行率以及高身体质量指数的负担:全球疾病负担研究2023的系统分析

2026-09-110
OAAI
Global, regional, and national cascades of diabetes care, 2000–23: a systematic review and modelling analysis using findings from the Global Burden of Disease Study

全球、区域和国家糖尿病护理的级联效应,2000–23年:一项基于全球疾病负担研究的系统评价和建模分析

2025-09-090
PRE
Development of a World Health Organization indicator and corresponding questions to measure effective coverage of rehabilitation

开发世界卫生组织指标及其对应问题,以衡量康复服务的有效覆盖率

2025-07-010
OA
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家糖尿病负担1990年2021年,以及患病率2050年预测: 全球疾病负担研究的系统分析2021

LANCET
IF88.5
2023-07-01941
OAAI
Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

估算新型冠状病毒肺炎大流行前秘鲁的死亡率和致残率: 来自全球疾病负担研究的系统分析2019

2023-06-225
OAAI
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis

既往SARS-CoV-2感染预防再感染的系统评价和荟萃分析

LANCET
IF88.5
2023-03-01211
OAAI
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

对大流行病防范和新型冠状病毒肺炎的全球投资: 发展援助和卫生1990年和2026的国内支出

2023-03-01140
OAAI
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019

1990至2019,对204个国家和地区的整体和选定年龄组的医疗保健获取和质量指数的评估: 来自全球疾病负担研究2019的系统分析

2022-12-0168
OAAI
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

有症状的新型冠状病毒肺炎2020年和2021后,持续存在乏力,认知和呼吸症状群的个体的估计全球比例

2022-10-25443
OA
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis

通过2021年11月14日估算全球,区域和国家每日和累积的SARS-CoV-2感染: 统计分析

LANCET
IF88.5
2022-06-01189
OAAI
Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021

量化新型冠状病毒肺炎大流行对性别平等对健康,社会和经济指标的影响: 对2020 3月至2021年9月的数据的全面审查

LANCET
IF88.5
2022-06-01181
OAAI